NDUFB9 Rabbit Polyclonal Antibody

CAT#: TA306948

Rabbit Polyclonal LYRM3 Antibody

Product Images

Western blot analysis of LYRM3 in human liver tissue lysate with LYRM3 antibody at (A) 1 and (B) 2 ug/mL.

• 

  Immunohistochemistry of LYRM3 in rat liver tissue with LYRM3 antibody at 5 ug/mL.

• 

  Immunofluorescence of LYRM3 in rat liver tissue with LYRM3 antibody at 20 ug/mL.

Specifications

Product Data

• Applications: IF, IHC, WB
• Recommended Dilution: WB: 1 - 2 ug/mL, ICC: 5 ug/mL, IF: 20 ug/mL
• Reactivities: Human, Mouse, Rat
• Host: Rabbit
• Isotype: IgG
• Clonality: Polyclonal
• Immunogen: LYRM3 antibody was raised against a 17 amino acid peptide near the carboxy terminus of human LYRM3.
• Formulation: PBS containing 0.02% sodium azide.
• Concentration: 1ug/ul
• Purification: Affinity chromatography purified via peptide column
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Gene Name: NADH:ubiquinone oxidoreductase subunit B9
• Database Link:
  NP_004996
  Entrez Gene 66218 MouseEntrez Gene 299954 RatEntrez Gene 4715 Human
  UniProt ID Q9Y6M9
• Background: LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
• Synonyms: B22; CI-B22; LYRM3; UQOR22

Reference Data

• Protein Pathways: Alzheimer's disease, Huntington's disease, Metabolic pathways, Oxidative phosphorylation, Parkinson's disease